Keyphrases
Non-small Cell Lung Cancer Cells
100%
A549
100%
Stemness
100%
Multidrug-resistant
100%
C-X-C Chemokine Receptor Type 4 (CXCR4)
100%
CXCR4 Expression
33%
Sphere Formation
33%
A549 Cells
22%
Mammalian Target of Rapamycin (mTOR)
22%
Pharmacological Inhibitors
22%
Self-renewal
22%
Sphere-forming
22%
Tumorigenicity
22%
Malignant Cells
11%
Phosphorylation
11%
Lung Cancer
11%
Phosphoinositide 3-kinase (PI3K)
11%
Human Lung Cancer Cell Line
11%
Stem Cells
11%
Akt Phosphorylation
11%
In Vitro Activity
11%
Cancer Cells
11%
STAT3 Signaling Pathway
11%
Putative Drug Targets
11%
Non-small Cell Lung Cancer (NSCLC)
11%
WP1066
11%
Downstream Effectors
11%
Therapeutic Failure
11%
H460 Cells
11%
AMD3100
11%
Gefitinib-resistant
11%
SiRNA Transfection
11%
Stromal Cell-derived factor-1 (SDF-1)
11%
Cancer Stem-like
11%
Tumorigenic Potential
11%
Lentiviral Transduction
11%
Epithelial-mesenchymal Transition
11%
Cancer Stem Cells
11%
Radiation Resistance
11%
Medicine and Dentistry
Cancer Cell
100%
Non Small Cell Lung Cancer
100%
Upregulation
100%
Malignant Neoplasm
50%
In Vitro
50%
Genetic Transfection
50%
Carcinogenicity
50%
Mammalian Target of Rapamycin
50%
Radiosensitivity
25%
Lung Cancer
25%
Fluorescence Activated Cell Sorting
25%
Secretion (Process)
25%
Phosphoinositide 3-Kinase
25%
Small Interfering RNA
25%
Plerixafor
25%
Stromal Cell Derived Factor 1
25%
Gefitinib
25%
Mesenchymal-Epithelial Transition
25%
Cancer Stem Cell
25%
3 (6 Bromo 2 Pyridinyl) 2 Cyano N (1 Phenylethyl)acrylamide
25%
Lung Cancer Cell Line
25%
Biochemistry, Genetics and Molecular Biology
Upregulation
100%
Cancer Cell
100%
CXCR4
100%
STAT3
41%
Transfection
16%
Mammalian Target of Rapamycin
16%
Wild Type
8%
Small Interfering RNA
8%
Secretion (Process)
8%
Phosphoinositide 3-Kinase
8%
Radiosensitivity
8%
Mesenchymal-Epithelial Transition
8%
Cancer Stem Cell
8%
Gefitinib
8%
Fluorescence Activated Cell Sorting
8%
Stromal Cell-Derived Factor 1
8%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Non Small Cell Lung Cancer
100%
Carcinogenicity
50%
Small Interfering RNA
25%
Phosphatidylinositol 3 Kinase
25%
Plerixafor
25%
Stromal Cell Derived Factor 1
25%
Fluorescence Activated Cell Sorting
25%
Lung Cancer
25%
Gefitinib
25%
3 (6 Bromo 2 Pyridinyl) 2 Cyano N (1 Phenylethyl)acrylamide
25%